We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




In Vitro Three-Dimensional Culture System Enhances Prostate Cancer Cell Growth

By LabMedica International staff writers
Posted on 07 Jul 2016
A team of cancer researchers developed a three-dimensional in vitro culture system for growing prostate cancer cells in an environment that closely mimics the in vivo tumor microenvironment.

The physical and mechanical properties of the tumor microenvironment are crucial for the growth, differentiation, and migration of cancer cells. More...
However, such a microenvironment is not reproduced in vitro due to the geometric constraints of the classic two-dimensional cell culture systems used in many cancer studies. Prostate cancer research, in particular, suffers from the lack of suitable in vitro models.

To correct this deficiency, investigators at the Karlsruhe Institute of Technology (Eggenstein-Leopoldshafen, Germany) generated a three-dimensional in vitro growth system based on a superporous scaffold prepared by cryogelation of poly(ethylene glycol) diacrylate. The resulting structure was a defined elastic matrix for prostate tumor growth with mechanical properties that were very similar to those of natural cell tissue.

The investigators reported in the May 30, 2016, online edition of the journal Small that lymph node carcinoma of the prostate (LNCaP) cells showed a linear growth over 21 days as multicellular tumor spheroids in such a scaffold with points of attachments to the walls of the scaffold. These LNCaP cells responded to the growth promoting effects of androgens and demonstrated a characteristic cytoplasmic-nuclear translocation of the androgen receptor and androgen-dependent gene expression.

Compared to two-dimensional cell culture, the expression or androgen response of prostate cancer specific genes was greatly enhanced in the LNCaP cells grown in the three-dimensional system.

"The paper covers the implementation of the model and shows that it is a long-term stable tissue-like three-dimensional cell culture system, with the help of which hormone-independent prostate-specific gene expression could not only be achieved, but even be reinforced compared to conventional two-dimensional models," said contributing author Dr. Friederike J. Gruhl, a researcher in the Institute of Microstructure Technology at the Karlsruhe Institute of Technology. "This was shown by the cultivation of androgen-sensitive prostate cancer cells (LNCaP). In future, it may be possible to cultivate both healthy cells of the prostate tissue and cancer cells in the three-dimensional cryogel model. This opens up new opportunities for preclinical research and for using it in the clinical development of anti-prostate cancer drugs."

Related Links:
Karlsruhe Institute of Technology


Gold Member
Veterinary Hematology Analyzer
Exigo H400
Serological Pipet Controller
PIPETBOY GENIUS
New
Automated Biochemical Analyzer
iBC 900
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.